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Abstract. In this article we present the Biochemical Abstract Machine
BIOCHAM and advocate its use as a formal modeling environment for
networks biology. Biocham provides a precise semantics to biomolecular
interaction maps. Based on this formal semantics, the Biocham system
offers automated reasoning tools for querying the temporal properties of
the system under all its possible behaviors. We present the main features
of Biocham, provide details on a simple example of the MAPK signaling
cascade and prove some results on the equivalence of models w.r.t. their
temporal properties.
1 Introduction
In networks biology, the complexity of the systems at hand (metabolic net-
works, extracellular and intracellular networks, networks of gene regulation)
clearly shows the necessity of software tools for reasoning globally about bio-
logical systems [1]. Several formalisms have been proposed in recent years for
modeling biochemical processes either qualitatively [2–4] or quantitatively [5–9].
State-of-the-art tools integrate a graphical user interface and a simulator, yet
few formal tools are available for reasoning about these processes and proving
properties about them. Our focus in Biocham has been on the design of a bio-
chemical rule language and a query language of the model in temporal logic,
that are intended to be used by biologists.
Biocham has been designed in the framework of the ARC CPBIO on “Process
Calculi and Biology of Molecular Networks” [10] which aims at pushing forward
a declarative and compositional approach to modeling languages in Systems
Biology. Biocham is a language and a programming environment for modeling
biochemical systems, making simulations, and checking temporal properties. It
is composed of :
1. a rule-based language for modeling biochemical systems, allowing patterns
and constraints in the definition of rules;
2. a simple simulator;
3. a powerful query language based on Computation Tree Logic CTL;
4. an interface to the NuSMV [11] model checker for automatically evaluating
CTL queries.
The use of Computation Tree Logic (CTL) [12] for querying the temporal
properties of the system provides an alternative technique to numerical models
based on differential equations, in particular when numerical data are miss-
ing. The model-checking tools associated to CTL automate reasoning on all the
possible behaviors of the system modeled in a purely qualitative way. The se-
mantics of Biocham ensures that the set of possible behaviors of the model over-
approximates the set of all behaviors of the system corresponding to different
kinetic parameters.
Biocham shares several similarities with the Pathway Logic system [4] imple-
mented in Maude. Both systems rely on an algebraic syntax and are rule-based
languages. One difference is the use in Biocham of CTL logic which allows us
to express a wide variety of biological queries, and the use of a state-of-the-art
symbolic model checker for handling the complexity of highly non-deterministic
models.
The first experimental results of this approach for querying models of bio-
chemical networks in temporal logic have been reported in [13, 14], on a qualita-
tive model of the mammalian cell cycle control [15, 16] and in [14] on a quantita-
tive model of gene expression [9]. In this paper we describe the Biocham system
which provides a modeling environment supporting this methodology.
The next section defines the syntax of Biocham objects, rules and patterns,
and their semantics. The following section describes the CTL query language
and the expression of biological queries. Then we detail Biocham functionalities
on a simple model of the MAPK signaling cascade. In section 5 we discuss the
comparison of different models of given biological systems and show two equiv-
alence results w.r.t. CTL properties. Section 6 reports our on-going experience
in applying inductive logic programming techniques to learning reaction rules
from temporal properties, and learning rule patterns from a given set of reaction
rules. Finally we compare our approach with related work and conclude on the
perspectives of this work.
2 Syntax and Semantics
2.1 A simple Algebra of Biochemical Compounds
Biocham manipulates formal objects which represent chemical or biochemical
compounds, ranging from ions, to small molecules, macromolecules and genes.
Biocham objects can be used also to represent control variables and abstract
biological processes.
Syntax:
object = molecule | abstract
molecule = name | molecule-molecule | molecule∼{name,...,name}
| gene | ( molecule )
gene = #name
abstract = @name
In the simplest and the most flexible syntactical form, a molecule is simply
given a name. Multimolecular complexes are denoted with the linking operator
-. This binary operator is assumed to be associative and commutative, hence the
order of the elements in a complex does not matter. Note that the same hypoth-
esis is made in Pathway Logic [4] and other systems [17]. In the cases where one
would like to distinguish between different orders of association, one can denote
the different complexes with specific names. A third syntactical form serves to
write modified forms of molecules, like attaching the set of phosphorylated sites
with the operator ∼. Several sets can be attached. The order of the elements is
irrelevant.
Example 1. RAF, RAF-RAFK and RAF~{p1}-MEK are valid Biocham notations for,
respectively, a Raf protein, its complex with a Raf-kinase, and an activated form
of Raf in the complex with the MAPK/ERK kinase.(RAF-MEK)~{p1} is another
notation for the same phosphorylated form of the complex without making pre-
cise the constituent which is phosphorylated. Precising or not the phosphorylated
constituent defines two formally different complexes. It is also possible to spec-
ify more precisely the phosphorylation, for instance by naming its sites, as in
RAF~{ser338,tyr341}, but then again, this defines a formally different molecule.
The fourth syntactical form is used to denote genes or gene promotors, with
a name beginning with #. These objects are assumed to be unique, which has
a consequence on the way reactions involving such objects are interpreted by
Biocham, as explained in the next section.
Example 2. DMP1-#p19ARF can be used to denote the binding of protein DMP1
on the promotor of the gene producing protein p19ARF noted #p19ARF.
The same assumption of uniqueness is made on abstract objects that are
noted with a ’@’. Abstract objects can be used to represent particular phases of
a process, complete subsystems or abstract biological processes.
Example 3. @UbiPro can be used to denote the Ubiquitine/Proteasome subsys-
tem and write this formal object as a catalyst in degradation reaction rules.
2.2 Reaction Rules
Biocham reaction rules are used primarily to represent biochemical reactions.
They can be used also to represent state transitions involving control variables
or abstract processes, or to represent the main effects of complete subsystems
such as protein synthesis by DNA transcription without introducing RNAs in
the model.
Syntax:
reaction = name: reaction
| solution => solution
| solution =[object]=> solution
| solution =[solution => solution]=> solution
| solution <=> solution
| solution <=[object]=> solution
solution = | object | solution + solution | ( solution )
A solution is thus a sum of objects, the character denotes the empty solu-
tion. The order and multiplicity of molecules in a solution are ignored, only the
presence or absence of objects are considered.
The following abbreviations can be used for reaction rules: A<=>B for the two
symmetrical rules, A=[C]=>B for the rule A+C=>B+C with catalyst molecule C,
and A=[C=>D]=>B for the rule A+C=>D+B.
Example 4. RAF + RAFK => RAF-RAFK is a complexation rule.
MEK =[RAF~{p1}]=> MEK~{p1} is a phosphorylation rule with catalyst RAF~{p1}.
This rule is equivalent to MEK + RAF~{p1} => MEK~{p1} + RAF~{p1}.
A reaction transforms one solution matching the left-hand side of the rule,
into another solution in which the objects of the right-hand side have been
added. The molecules in the left-hand side of the rule which do not appear in
the right-hand side may be non-deterministically present or consumed in the
resulting solution. This convention defines the boolean abstraction of stoichio-
metric models used in Biocham. It reflects the capability of Biocham to reason
about all possible behaviors of the system with unknown concentration values
and unknown kinetics parameters [1, 3].
Following the uniqueness assumption, molecule parts marked as ”genes”
with the ’#’ notation, or any compound built on such a molecule (such as
DMP1-#p19ARF for instance) are not multiplied. These objects remain unique
and they are deterministically consumed in the form in which they appear in
the left-hand side of the rule. The same goes for control variables, noted with a
’@’, which are deterministically consumed.
Biocham has also a rich pattern language with constraints which is used to
specify molecules and sets of reaction rules in a concise manner, it is detailed in
the next section.
2.3 Patterns
Patterns introduce the special character ? and variables noted with a name
beginning with a $ to denote unspecified parts of a molecule. These variables
can be constrained with simple set constraints.
Example 5. list_rules(RAF~?-? + ? => ?).
This command contains a pattern matching all rules reacting with any form
(phosphorylated or complexed) of RAF.
list_rules(? =[RAFK]=> ?).
This pattern is matching all rules involving the catalyst RAFK, i.e. having RAFK
in their left and right-hand sides, even if they were not written with the catalyst
notation.
With some restrictions, patterns can be used to define reaction rules. This
is not the case of the above example as the patterns can match unspecified
(unconstrained) molecules. Two constructs are provided in Biocham to specify
the domains of variables either globally or locally to a rule:
– declare: allowing to define all the phosphorylation sites of a molecule;
– where: imposing local constraints on variables in a rule declaration.
Example 6. declare MEK~{{},{p1},{p2},{p1,p2}}.
declare MAPK~parts_of({p1,p2}).
...
MEK~$P + RAF~{p1} <=> MEK~$P-RAF~{p1}
where p2 not in $P.
and $cycA in {cycA, cks1-cycA}
In this context, MEK is declared to have two phosphorylation sites p1, p2
and that all combinations are possible, MAPK has two sites too, with again all
combinations allowed.
Then appears a reaction pattern which specifies the complexation or decom-
plexation of some forms of MEK not already phosphorylated on p2. This pattern
is used to define reactions. There are 2 possible forms (not containing p2) for
$P to combine with the 2 possibilities for the direction of the rule. This reaction
pattern thus expands into 4 reaction rules.
Section 4 contains a Biocham model of the MAPK signaling cascade written
with a set of 16 reaction rule patterns which expand into 30 rule instances.
2.4 Kripke Semantics
A Biocham model is a set of reaction rules given with an initial state. As any
rule pattern can be expanded into a set of reaction rules, there is no loss of
generality in considering only reaction rules. The formal semantics of a Biocham
model is a Kripke structure that is a mathematical structure which provides a
firm ground for :
– comparing different modeling formalisms and languages,
– comparing different models of a same biological system,
– importing models from other sources,
– and designing and implementing automated reasoning tools.
A Kripke structure K is a triple (S,R,L) where S is the set of states, R ⊆
S × S is a total relation (i.e. for any state s ∈ S there exists a state s′ ∈ S
such that (s, s′) ∈ R) called transition, and L : S → 2A is a labeling function
over the set of atomic propositions A, which associates to each state the set of
atomic propositions true in that state. A path in K starting from a state s0 is
an infinite sequence of states π = s0, s1, ... such that (si, si+1) ∈ R for all i ≥ 0.
Clearly, one can associate to a Biocham model a Kripke structure, where the
set of states S is the set of all tuples of boolean values denoting the presence or
absence of the different biochemical compounds (molecules, genes and abstract
processes), the transition relation R is the union (i.e. disjunction) of the rela-
tions associated to the reaction rules (which will be noted →), and the labeling
function L simply associates to a given state the set of biochemical compounds
which are present in the state. Reaction rules in Biocham are asynchronous in
the sense that one reaction rule is fired at a time (interleaving semantics), hence
the transition relation is the union of the relations associated to the reaction
rules On the other hand, in a synchronous semantics for Biocham, the transition
relation would have been defined by intersection. The choice of a synchronous
semantics has been rejected in Biocham as it would bias fundamental biological
phenomena such as the masking of a relation by another one and the resulting in-
hibition or activation of biological processes. Note that as explained in Sect. 2.2,
the boolean abstraction of enzymatic reactions used in Biocham associates sev-
eral transitions to a single Biocham reaction rule, one for each case of possible
consumption of the molecules in the left-hand side of the rule.
That Kripke structure defines the semantics of a Biocham model as a non-
deterministic transition system where the temporal evolution of the system is
modeled by the succession of transition steps, and the different possible behaviors
of the system are obtained by the non-deterministic choice of reactions.
3 Querying Biocham Models in Temporal Logic CTL
Thanks to its simple Kripke semantics, Biocham supports the use of the Com-
putation Tree Logic CTL [12] as a query language for querying the temporal
properties of Biocham models. This methodology introduced in [13, 14] is im-
plemented in Biocham with an interface to the state-of-the-art symbolic model
checker NuSMV [11].
CTL basically extends propositional logic used for describing states, with op-
erators for reasoning over time and non-determinism. Several temporal operators
are introduced in CTL: Xφ meaning φ is true at next transition, Gφ meaning φ
is always true, Fφ meaning finally true, and φUψ meaning φ is always true until
ψ becomes true. For reasoning about non-determinism, two path quantifiers are
introduced: Aφ meaning φ is true on all paths, Eφ meaning φ is true on some
path. In CTL, all temporal operators must be immediately preceded by a path
quantifier (e.g. AFGφ is not in CTL, but AF (EGφ) is).
CTL is expressive enough to express a wide range of biological queries. Sim-
plest queries are about reachability: is there a pathway for synthesizing a pro-
tein P , EF (P ) ? About pathways: can the cell reach a state s while passing
by another state s2, EF (s2 ∧ EF (s)) ? Is state s2 a necessary checkpoint for
reaching state s, ¬E((¬s2) U s)? Can the cell reach a state s without violating
certain constraints c, E(c U s)? Is it possible to synthesize a protein P with-
Table 1. Inductive definition of the truth relations s |= φ and π |= φ in a given Kripke
structure K.
s |= α iff α ∈ L(s),
s |= Eψ iff there is a path π from s such that π |= ψ,
s |= Aψ iff for every path π from s, π |= ψ,
π |= φ iff s |= φ where s is the starting state of π,
π |= Xψ iff π1 |= ψ,
π |= Fψ iff there exists k ≥ 0 such that πk |= ψ,
π |= Gψ iff for every k ≥ 0, πk |= ψ,
π |= ψUψ′ iff there exists k ≥ 0 such that πk |= ψ′ and πj |= ψ for all 0 ≤ j < k.
out creating nor using protein Q, I ⇒ E(¬Q U P )? About steady states and
permanent states: is a certain (partially described) state s of the cell a steady
state, s ⇒ EG(s)? a permanent state, s ⇒ AG(s)? Can the cell reach a given
permanent state s, EF (AGs)? Must the cell reach a given permanent state s,
AF (AGs)? Can the system exhibit a cyclic behavior w.r.t. the presence of a
product P , EG((P ⇒ EF ¬P ) ∧ (¬P ⇒ EF P ))? The latter formula expresses
that there exists a path where at all time points whenever P is present it becomes
eventually absent, and whenever it is absent it becomes eventually present. This
formula is not expressible in LTL [12], where formulas are of the form Aφ with
φ containing no path quantifier.
The formal semantics of CTL in a fixed Kripke structure K is given in Table
1, as the inductive definition of the truth relation stating that a CTL formula
φ is true at state s, written s |= φ, or true along path π, written π |= φ (the
clauses for ordinary boolean connectives are omitted). πi denotes the suffix of π
starting at si.
4 A Simple Example
The Mitogen-Activated Protein Kinase (MAPK) cascades are a well-known ex-
ample of signal transduction, since they appear in many receptor-mediated signal
transduction schemes. They are actively considered in pharmaceutical research,
for their applications to cancer therapies. The MAPK/ERK pathway is indeed
hyperactivated in 30% of all human cancer tumours [18].
The structure of a MAPK cascade is a sequence of activations of three kinases
in the cytosol. The last kinase, MAPK, when activated, has an effect on different
substrates in the cytosol but also on gene transcription in the nucleus.
Since this cascade has been studied a lot, mathematical models of it appear
in most model repositories, like for instance that of Cellerator [19] or the SBML
repository page [20], both coming from [21]. This cascade was also the first
example treated by Regev, Silverman and Shapiro [2] in the pi-calculus process
algebra which was an initial source of inspiration for our own work.
Models based on ordinary differential equations (ODE) allow us to reproduce
simulation results like the one pictured out in Figure 1, where the concentration
of the visualized compounds is represented on the vertical axis and time on the
horizontal axis. In Figure 2, the concentrations axis has been simply split and
rescaled to the maximum value for each compound.
RAFK
RAF
MEK
MAPK
RAF~{p1}
MEK~{p1}
MEK~{p1,p2}
MAPK~{p1}
MAPK~{p1,p2}
Fig. 1. Simulation result of an ODE model of the MAPK cascade.
It is possible to see from such simulations how the cascade evolves in time.
It is possible to change input quantities to check for a significant change in the
outcome of the simulation. Similarly, the sensitivity of the system to the values
of the parameters can be checked by running different simulations with different
values of the parameters.
4.1 The MAPK cascade in Biocham Syntax
Our aim in Biocham is to introduce complementary techniques to automate rea-
soning on all possible behaviors of the system modeled in a purely qualitative
way. Taking the above model, one sees that it is built quite directly from the en-
zymatic reactions and Michaelis-Menten kinetics. Abstracting the kinetics part,
one gets a system of biochemical reactions that can be interpreted as a non-
deterministic transition system over boolean variables denoting the presence or
absence of the compounds in the signaling cascade. The semantics of Biocham
(explained in Sects. 2.2 and 2.4) ensures that the set of the possible behaviors of
the boolean model over-approximates the set of all behaviors of the system for
all kinetic parameters’ values.
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Fig. 2. Same simulation as figure 1, side by side rescaled view.
Here is the full code of the MAPK example1 in Biocham syntax. The phos-
phorylation sites for MEK and MAPK are declared first, and then the Biocham rules
are given, sometimes with pattern variables (noted $P) which are constrained in
the where part of the rules. In this model, the first rules are reversible, the other
ones are directional.
declare MEK~parts_of({p1,p2}).
declare MAPK~parts_of({p1,p2}).
RAF + RAFK <=> RAF-RAFK.
RAF~{p1} + RAFPH <=> RAF~{p1}-RAFPH.
MEK~$P + RAF~{p1} <=> MEK~$P-RAF~{p1}
where p2 not in $P.
MEKPH + MEK~{p1}~$P <=> MEK~{p1}~$P-MEKPH.
MAPK~$P + MEK~{p1,p2} <=> MAPK~$P-MEK~{p1,p2}
where p2 not in $P.
MAPKPH + MAPK~{p1}~$P <=> MAPK~{p1}~$P-MAPKPH.
RAF-RAFK => RAFK + RAF~{p1}.
1 adapted from the SBML model http://www-aig.jpl.nasa.gov/public/mls/
cellerator/notebooks/MAPK-in-solution.html
RAF~{p1}-RAFPH => RAF + RAFPH.
MEK~{p1}-RAF~{p1} => MEK~{p1,p2} + RAF~{p1}.
MEK-RAF~{p1} => MEK~{p1} + RAF~{p1}.
MEK~{p1}-MEKPH => MEK + MEKPH.
MEK~{p1,p2}-MEKPH => MEK~{p1} + MEKPH.
MAPK-MEK~{p1,p2} => MAPK~{p1} + MEK~{p1,p2}.
MAPK~{p1}-MEK~{p1,p2} => MAPK~{p1,p2} + MEK~{p1,p2}.
MAPK~{p1}-MAPKPH => MAPK + MAPKPH.
MAPK~{p1,p2}-MAPKPH => MAPK~{p1} + MAPKPH.
These rule patterns define the following set of expanded reaction rules:
biocham: expand_rules.
1 RAF+RAFK=>RAF-RAFK.
2 RAF-RAFK=>RAF+RAFK.
3 RAF~{p1}+RAFPH=>RAFPH-RAF~{p1}.
4 RAFPH-RAF~{p1}=>RAF~{p1}+RAFPH.
5 MEK+RAF~{p1}=>MEK-RAF~{p1}.
6 MEK-RAF~{p1}=>MEK+RAF~{p1}.
7 MEK~{p1}+RAF~{p1}=>MEK~{p1}-RAF~{p1}.
8 MEK~{p1}-RAF~{p1}=>MEK~{p1}+RAF~{p1}.
9 MEKPH+MEK~{p1}=>MEKPH-MEK~{p1}.
10 MEKPH-MEK~{p1}=>MEKPH+MEK~{p1}.
11 MEKPH+MEK~{p1,p2}=>MEKPH-MEK~{p1,p2}.
12 MEKPH-MEK~{p1,p2}=>MEKPH+MEK~{p1,p2}.
13 MAPK+MEK~{p1,p2}=>MAPK-MEK~{p1,p2}.
14 MAPK-MEK~{p1,p2}=>MAPK+MEK~{p1,p2}.
15 MAPK~{p1}+MEK~{p1,p2}=>MAPK~{p1}-MEK~{p1,p2}.
16 MAPK~{p1}-MEK~{p1,p2}=>MAPK~{p1}+MEK~{p1,p2}.
17 MAPKPH+MAPK~{p1}=>MAPKPH-MAPK~{p1}.
18 MAPKPH-MAPK~{p1}=>MAPKPH+MAPK~{p1}.
19 MAPKPH+MAPK~{p1,p2}=>MAPKPH-MAPK~{p1,p2}.
20 MAPKPH-MAPK~{p1,p2}=>MAPKPH+MAPK~{p1,p2}.
21 RAF-RAFK=>RAFK+RAF~{p1}.
22 RAFPH-RAF~{p1}=>RAF+RAFPH.
23 MEK~{p1}-RAF~{p1}=>MEK~{p1,p2}+RAF~{p1}.
24 MEK-RAF~{p1}=>MEK~{p1}+RAF~{p1}.
25 MEKPH-MEK~{p1}=>MEK+MEKPH.
26 MEKPH-MEK~{p1,p2}=>MEK~{p1}+MEKPH.
27 MAPK-MEK~{p1,p2}=>MAPK~{p1}+MEK~{p1,p2}.
28 MAPK~{p1}-MEK~{p1,p2}=>MAPK~{p1,p2}+MEK~{p1,p2}.
29 MAPKPH-MAPK~{p1}=>MAPK+MAPKPH.
30 MAPKPH-MAPK~{p1,p2}=>MAPK~{p1}+MAPKPH.
The Biocham rules can be exported to a .dot file for use with the Graphviz2
visualization suite. The generated map is depicted in Figure 3.
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Fig. 3. Interaction map generated from BIOCHAM rules for the MAPK cascade.
4.2 Simulation
Since a Biocham model is highly non-deterministic, simulations are randomized,
which means that at each time step, one of the possible reactions happens. An
initial state can be defined by taking present the following molecules:
2 http://www.research.att.com/sw/tools/graphviz/
present({
RAFK,
RAF,
MEK,
MAPK,
MAPKPH,
MEKPH,
RAFPH
}).
and absent the following ones:
absent({?-?,?~{p1}~?}).
The last pattern declares the complexes (?-?) and the molecules phospho-
rylated at p1 (?~{p1}~?) as absent from the initial state. It is equivalent to the
following sequence:
absent(RAF-RAFK).
absent(RAFPH-RAF~{p1}).
absent(MEK-RAF~{p1}).
absent(MEK~{p1}-RAF~{p1}).
absent(MEKPH-MEK~{p1}).
absent(MEKPH-MEK~{p1,p2}).
absent(MAPK-MEK~{p1,p2}).
absent(MAPK~{p1}-MEK~{p1,p2}).
absent(MAPKPH-MAPK~{p1}).
absent(MAPKPH-MAPK~{p1,p2}).
absent(RAF~{p1}).
absent(MEK~{p1}).
absent(MEK~{p1,p2}).
absent(MAPK~{p1}).
absent(MAPK~{p1,p2}).
Figure 4 depicts one random simulation of the MAPK cascade, that is one
but only one possible behavior of the system at the boolean abstraction level.
One can notice that this trace is not a boolean abstraction (by thresholds) of
the numerical simulation. On the other hand, the numerical simulation can be
abstracted in a feasible boolean trace.
4.3 CTL Queries
Biocham uses the Computation Tree Logic (CTL) [12] as a query language for
querying the temporal properties of the system under all possible conditions.
Querying a Biocham model in CTL temporal logic provides a mean to analyze
exhaustively all possible behaviors of the system from first principles of enzy-
matic reactions, in particular when numerical data are not available.
A biological query like for example “Is the activation of the second kinase of
the cascade (MEK) compulsory for the cascade ?” asks whether the phosphory-
lated form of MEK, noted in Biocham MEK~{p1}, is necessary to the production
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Fig. 4. Random simulation of the Biocham model of the MAPK cascade
of the activated MAPK, noted MAPK~{p1,p2}, which is the output of the cas-
cade, that is whether MEK~{p1} is a checkpoint. In Biocham, one expresses this
query by the CTL formula
biocham: !(E(!(MEK~{p1}) U MAPK~{p1,p2}))
true
This formula expresses the non (!) existence (E) of a path on which MEK~{p1}
is absent (!) until (U) MAPK~{p1,p2} becomes present, that is to say that MEK~{p1}
is a checkpoint. This formula is checked automatically by the system.
The same query about a complex with a phosphatase, such as the complex
MEK~{p1}-MEKPH, is false. These complexes are thus not checkpoints. The why
command computes a counterexample in the form of a pathway which validates
the negation of the query:
biocham: !(E(!(MEK~{p1}-MEKPH) U MAPK~{p1,p2}))
false
biocham: why
Step 1 Initial state
Step 2 rule 1 RAF-RAFK present
Step 3 rule 21 RAF~{p1} present
Step 4 rule 5 MEK-RAF~{p1} present
Step 5 rule 24 MEK~{p1} present
Step 6 rule 7 MEK~{p1}-RAF~{p1} present
Step 7 rule 23 MEK~{p1,p2} present
Step 8 rule 13 MAPK-MEK~{p1,p2} present
Step 9 rule 27 MAPK~{p1} present
Step 10 rule 15 MAPK~{p1}-MEK~{p1,p2} present
Step 11 rule 28 MAPK~{p1,p2} present
This means that the complexes with a phosphatase (xxxPH) are intermediate
products that do not strictly participate in the signal transduction. They are here
to regulate the cascade, but they are not mandatory for the signal transduction
in this model. A similar trace is obtained when asking a simple accessibility
query like EF(MAPK~{p1,p2}), that is the existence (E) of a path on which at
some time point (F) MAPK is fully phosphorylated.
It is worth noting that imposing the absence of an intermediate product is
generally difficult in an ODE based simulation tool, without touching the model.
Complex CTL queries thus have no natural counterpart in a numerical model
and complement the information that can be deduced from interaction maps.
The largest example treated so far with Biocham is a model of the Mam-
malian cell cycle control [13] developed after Kohn’s map [16], involving 500
proteins and genes and 147 rule patterns which expand into 2733 rule instances.
The computational results reported in [13] show the feasibility of this approach
on such large examples as the CTL queries can be evaluated in a few seconds
using state-of-the-art symbolic model-checking tools.
5 Comparing Models
5.1 Importing Biochemical Models from Other Formalisms
Since the basic building block of a Biocham model is an (enzymatic) reaction,
it is quite easy to import any model based on such reactions into Biocham.
This is the case of most graphical map-based models, but also of some ODE
models, derived from the mass-action law or Michaelis-Menten kinetics. A well
known source of such models is KEGG [22], which provides (graphical) maps of
metabolic and signaling pathways. Biocham has been designed to provide such
maps with a simple yet precise semantics.
In this respect, the Biocham project is part of the workpackage entitled
“Towards a Bioinformatics Semantic Web” in the EU network REWERSE3.
5.2 CTL-based Equivalence of Models
There are usually lots of different possible models for a same system, depending
on the level of detail and of the available knowledge of that system. Even at
the level of a single enzymatic reaction, there are already two common ways to
specify it into Biocham:
either by detailing the formation of an unstable complex:
A + B <=> D
D => A + C
3 The 6th EU Framework Programme Network of Excellence REWERSE stands for
REasoning on the WEb with Rules and SEmantics, see http://www.rewerse.net
or directly, as
A + B => A + C (which can also be written B =[A]=> C)
The first model is a direct translation of common ODE numerical models.
However when converting to Biocham, the second model may be more natural as
it is simpler. We provide below some equivalence results w.r.t. the CTL properties
of both modelings.
We suppose that the complex D only appears in the above rule, as other-
wise the simplification is obviously not correct. Let us write K1 for the Kripke
structure associated with the first modeling, and K2 for that associated with the
second. These structures define two truth relationships: |=1 and |=2.
Proposition 1 (Reachability). Let φ be an atomic CTL formula, if I |=2
EF (φ) then I |=1 EF (φ).
Moreover, if A and B do not appear negatively (i.e. under an odd number of
negations) in φ and D does not appear at all in φ, then I |=1 EF (φ) implies
I |=2 EF (φ).
Proof. Let us first detail the transitions associated with the Biocham rules. In
K1 we have:
1. A + B → A + B + D
2. A + B → A + D
3. A + B → B + D
4. A + B → D
5. D → A + B + D
6. D → A + B
7. D → A + C + D
8. D → A + C
In K2:
1. A + B → A + B + C
2. A + B → A + C
The first implication is straightforward, since whenever there exists a path in
K2 there exists a path in K1, which is identical except for the transitions using
A + B → A + C that can be replaced by two transitions: A + B → D and D →
A + C, and those using A + B → A + B + C that can be replaced by A + B →
B + D and D → A + C.
For the second implication, if the path of K1 making φ true ends in a state
without D, then it is easy to mimick it in K2 with transitions 1 and 2. Otherwise,
one can reason by induction on the transition to prove that the previous state
without D also made φ true. For each of the transitions 1 to 4 (of K1) if the right
part |= φ then the left part |= φ. For instance for transition 2, we have A + B +
E → A + D + E, where A + D + E |= φ, but since D does not appear in φ and
B does not appear negatively in φ we have A + B + E |= φ. If the last step is
the use of 5 or 7, we do not need the induction: since D does not appear in φ,
replacing it with respectively 6 or 8 is enough to get a path ending without D
and making φ true. ut
Proposition 2 (Checkpoints). Let ¬E(¬φUψ) be a checkpoint formula, i.e.
φ and ψ are atomic formulae describing states,
if A and B do not appear negatively in ψ and D do not appear positively in ψ,
then
I |=2 ¬E(¬φUψ) implies I |=1 ¬E(¬φUψ).
if A and B do not appear negatively in φ and D do not appear positively in φ,
then
I |=1 ¬E(¬φUψ) implies I |=2 ¬E(¬φUψ).
Proof. Let first remind the meaning of I |= ¬E(¬φUψ): it means that there exist
no path π leading to ψ such that φ is false in each state of π.
For the first implication, let us consider a path π leading to ψ in K1; if π ends
in a state where D is absent, then one can consider a path π′ in K2, obtained in
the same way as in the previous proposition. This path is still leading to ψ in
K2, contains fewer states, φ is true in at least one of those states, and thus in
one of the states of π. If π ends in a state where D is present, the only difference
between that state and the previous (or next) state where D was not present
amounts to the appearance of D and possible disappearance of A and B and none
of those can be checked by ψ (since it is not positive in D nor negative in A or
in B), thus ψ was already true in the state where D was not present and we can
apply the above reasoning to get a state where φ is true.
For the reverse, let π be a K2 path leading to ψ, there exists a K1 path π
′
leading to the same state, obtained as in the previous proposition. We know that
some state s of π′ makes φ true, and if s is also in π then we are done. Otherwise
s is a state such that D is present and once again the only differences with the
previous state without D amount to D, A and B and because of the hypotheses
made for φ, φ was already true in the state without D, and thus φ is true in a
state of π. ut
5.3 Enriching Models
To go one step further, there is the need to encompass models written in different
formalisms and languages. The CMBSlib [23] web site4 has been created as an
open repository of computational models of biological systems, in order to:
– compare different models expressed in the same formalism,
– compare different formalisms and tools for a same model,
– cross-fertilize modeling experience and language issues between designers.
This library currently includes models of biological processes obtained from the
literature and by translation from KEGG maps or ODE models into different
formalisms. It is open to all contributions in any (ascii) format and in most
exotic formalisms.
4 http://contraintes.inria.fr/CMBSlib
6 Learning
6.1 Learning Reaction Rules from Temporal Properties
With such a simple syntax and semantics for describing reaction rules in Biocham,
it is possible to apply learning techniques to reaction rules discovery. We have
done some preliminary experiments using the inductive logic programming sys-
tem Progol [24] for the automatic discovery of missing Biocham reaction rules
in a simple model of the cell cycle with 10 variables, given a set of accessibility
properties. The basic experiment consists in furnishing a set of examples of ac-
cessibility relations and a set of counterexamples, and letting the inductive logic
program search for a set of reaction rules satisfying the accessibility properties
of the system. In the first phase of validation of the learning technique, where
we are, the models we use are known models, from which we compute a set of
temporal properties, and remove one or more reaction rules to check whether
the missing rules can be recovered by learning from the temporal properties.
More generally, the basic idea is to specify the intended or observed temporal
properties of the system with CTL formulas, and apply learning techniques such
as inductive logic programming, in order to correct the model by suggesting to
add or modify Biocham rules in the model5.
6.2 Learning Patterns as Generalizations of Existing Rules
The same kind of learning techniques, namely inductive logic programming, can
also be applied to the search of generalizations of existing rules, or even of
appearing compounds, by the means of Biocham’s pattern language.
Since the patterns allow basically rules with variables and constraints on
these variables, it is quite straightforward to try and learn such patterns from
existing models. Here again the status is that of preliminary experiments, but
there is much hope in using this technique to complete partial models.
7 Related Work
High-throughput technologies addressing cell functions at a whole genome scale
are revolutionizing cell biology. The challenge of virtual cell projects is to map
molecular interactions within the cell, and to build virtual cell models predicting
the effects of a drug on a given cell.
Virtual cell environments, like for instance the Virtual Cell project [25] or
Cellerator [19], maintain a library of models of different parts of the cell, among
different living organisms. ODE models typically range from a tenth of variables
to 50 variables like in the Budding Yeast cell Cycle model of [26]. On the other
hand, qualitative models represented by interaction maps allow for the global
modeling of a large number of interacting subsystems.
5 We investigate this approach in the 6th PCRD EU project APRIL 2 ”Applications
of Probabilistic Inductive Logic Programming”, http://www.aprill.org.
A formal model of the Mammalian cell cycle control has been developed in the
ARC CPBIO [13, 10] after Kohn’s map [16]. This model transcribed in Biocham
involves 500 proteins and genes and 147 reaction rule patterns which expand
into 2733 reaction rule instances. Performance results of CTL querying in this
model are reported in [13]. Symbolic model checking techniques used in Biocham
are efficient enough to automatically evaluate CTL queries about biochemical
networks of several hundreds or thousands of rules and variables [13, 14]. It is
worth noting however that this is far below the size of digital circuits that the
same model checking algorithms can treat. The reason for this discrepancy in
performance comes from the high level of non-determinism which results from the
competition between reaction rules and the soup aspect of biochemical solutions.
The Pathway Logic of [4] is close to Biocham for the algebraic representation
of cell compounds and the representation of molecular interactions by rewriting
rules. However, the boolean abstraction used in Biocham and the state-of-the-
art symbolic model checker NuSMV permit the handling of potentially larger
models. The choice of CTL for expressing biological queries provides also more
expressiveness than LTL, which is used in Pathway Logic. Much can be gained
by exchanging Biocham and Pathway Logic models, cross-fertilizing our model-
ing experiences and comparing language issues in particular w.r.t. the pattern
language. The CMBSlib open repository [23] has been created for this purpose
as well as for comparison with very different formalisms.
Combining ODE models with purely qualitative models like current Biocham
models is an important issue for managing the complexity of concurrent inter-
acting models. This combination is under investigation within the framework of
non-deterministic hybrid systems.
8 Conclusion and Perspectives.
Biocham is a free software6 for modeling biochemical processes and querying
these models in temporal logic. The largest example treated so far is a model of
the mammalian cell cycle control [13] after Kohn’s diagram [16]. Other models
have been imported from interaction maps available on the Web and ODE mod-
els. This shows the simplicity of the scheme and the flexibility of this approach.
Our first experiments for learning reaction rules from a partial model and
reachability properties of the system are encouraging. We are still in the phase
of validating the learning method based on Inductive Logic Programming. The
next phase will be, in collaboration with biologists, to try to apply learning
techniques to the discovery of new reaction rules.
Currently, Biocham is primarily oriented towards the qualitative modeling
of biochemical processes and the querying of the temporal properties of boolean
models. This approach can be generalized however to numerical models by rely-
ing on constraint-based model checking techniques [14]. In this extension, called
Biocham2, variables can denote real values expressing the concentrations of
6 Biocham system can be downloaded from http://contraintes.inria.fr/BIOCHAM
molecules, and rules are extended with constraints to denote the relationship
between the old and the new values of the variables. In particular, biochemical
systems described by differential equations can be handled in this framework us-
ing time discretization methods, and can be combined with boolean models. The
modeling power of such non-deterministic hybrid systems is under investigation.
Acknowledgments
This work benefited from various discussions with our colleagues of the ARC
CPBIO, in particular with Alexander Bockmayr, Vincent Danos and Vincent
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